Detection of carbapenemase-encoding genes among clinical isolates of pseudomonas aeruginosa in a Chinese burn unit

Journal of Burn Care and Research

Volumn 34, Issue 4, 2013, Pages 453-458

  Sun, Feng Jun ^a   Shi, Hui Qing ^a   Zhang, Xiao Bing ^a   Fang, Ya Dong ^a   Chen, Yong Chuan ^a   Chen, Jian Hong ^a   Wang, Qian ^a   Yang, Bo ^a   Feng, Wei ^a   Xia, Pei Yuan ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEMASE; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; GENOMIC DNA; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METALLO BETA LACTAMASE; NETILMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ADOLESCENT; ADULT; AGAR DILUTION; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BURN PATIENT; BURN UNIT; CHILD; CHINA; CONTROLLED STUDY; DISK DIFFUSION; FEMALE; GENE SEQUENCE; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; PSEUDOMONAS AERUGINOSA; RANDOM AMPLIFICATION OF POLYMORPHIC DNA POLYMERASE CHAIN REACTION; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; BURN UNITS; BURNS; CHILD; CHILD, PRESCHOOL; CHINA; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; YOUNG ADULT;

EID: 84881126440     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e3182700afd     Document Type: Article

References (24)

1. Barrow RE, Spies M, Barrow LN, Herndon DN. Influence of demographics and inhalation injury on burn mortality in children. Burns 2004;30: 72-7. (Pubitemid 38029127)
2. Wang Y, Tang HT, Xia ZF, et al. Factors affecting survival in adult patients with massive burns. Burns 2010;36: 57-64.
3. Lautenbach E, Synnestvedt M, Weiner MG, et al. Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes. Infect Control Hosp Epidemiol 2010;31: 47-53.
4. Ressner RA, Murray CK, Griffith ME, Rasnake MS, Hospenthal DR, Wolf SE. Outcomes of bacteremia in burn patients involved in combat operations overseas. J Am Coll Surg 2008;206: 439-44.
5. Juan C, Macia MD, Gutierrez O, Vidal C, Perez JL, Oliver A. Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains. Antimicrob Agents Chemother 2005;49: 4733-8. (Pubitemid 41552606)
6. Tomas M, Doumith M, Warner M, et al. Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother 2010;54: 2219-24.
7. Zhao WH, Hu ZQ. Beta-lactamases identified in clinical isolates of Pseudomonas aeruginosa. Crit Rev Microbiol 2010;36: 245-58.
8. Queenan AM, Bush K. Carbapenemases: the versatile betalactamases. Clin Microbiol Rev 2007;20: 440-58, table of contents.
9. Walsh TR. Clinically significant carbapenemases: an update. Curr Opin Infect Dis 2008;21: 367-71.
10. Yong D, J. M. Bell, B. Ritchie, et al. A novel sub-group metallo-lactamase (MBL), AIM-1 emerges in Pseudomonas aeruginosa (PSA) from Australia. [Abstract]. In: 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 17-20, 2007, Chicago, IL; C1-593, p. 75.
11. Nazik H, Ongen B, Erturan Z, Salcioglu M. Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients. Jpn J Infect Dis 2007;60: 82-6. (Pubitemid 47009521)
12. Giske CG, Libisch B, Colinon C, et al. Establishing clonal relationships between VIM-1-like metallo-beta-lactamaseproducing Pseudomonas aeruginosa strains from four European countries by multilocus sequence typing. J Clin Microbiol 2006;44: 4309-15. (Pubitemid 44937057)
13. Hodle AE, Richter KP, Thompson RM. Infection control practices in U.S. burn units. J Burn Care Res 2006;27: 142-51. (Pubitemid 43970314)
14. Wang WK, Han LZ, Yang L, Ni YX. [Analysis of the molecular epidemiology and distribution of pathogenic bacteria in burn wards of Ruijin Hospital from 2004 to 2006]. Zhonghua Shao Shang Za Zhi 2009;25: 94-7.
15. Song W, Lee KM, Kang HJ, Shin DH, Kim DK. Microbiologic aspects of predominant bacteria isolated from the burn patients in Korea. Burns 2001;27: 136-9. (Pubitemid 32156986)
16. Mirsalehian A, Feizabadi M, Nakhjavani FA, Jabalameli F, Goli H, Kalantari N. Detection of VEB-1, OXA-10 and PER-1 genotypes in extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients. Burns 2010;36: 70-4.
17. Guggenheim M, Zbinden R, Handschin AE, Gohritz A, Altintas MA, Giovanoli P. Changes in bacterial isolates from burn wounds and their antibiograms: a 20-year study (1986-2005). Burns 2009;35: 553-60.
18. Thabet L, Memmi M, Turki A, Messadi AA. The impact of fluoroquinolones use on antibiotic resistance in an intensive care burn department. Tunis Med 2010;88: 297-300.
19. Messadi AA, Lamia T, Kamel B, Salima O, Monia M, Saida BR. Association between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in an intensive care burn unit: a 5-year study, 2000-2004. Burns 2008;34: 1098-102.
20. Wang J, Zhou JY, Qu TT, et al. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals. Int J Antimicrob Agents 2010;35: 486-91.
21. Yang CH, Lee S, Su PW, Yang CS, Chuang LY. Genotype and antibiotic susceptibility patterns of drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates in Taiwan. Microb Drug Resist 2008;14: 281-8.
22. Chu YW, Afzal-Shah M, Houang ET, et al. IMP-4, a novel metallo-beta-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob Agents Chemother 2001;45: 710-4. (Pubitemid 32182013)
23. Campbell M, Mahenthiralingam E, Speert DP. Evaluation of random amplified polymorphic DNA typing of Pseudomonas aeruginosa. J Clin Microbiol 2000;38: 4614-5. (Pubitemid 32244557)
24. Rodriguez-Martinez JM, Poirel L, Nordmann P. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009;53: 4783-8.